Abstract:Celiac disease (CD) is an immune-mediated disease in which gluten causes damage to the small intestinal mucosa in genetically sensitive people. It can show in a variety of ways, from classic gastrointestinal or extraintestinalsymptomstoasymptomaticvariants.Todate,theonlytreatmentforCDisastrict,lifetime gluten-free diet (GFD). According to the findings, as little as 50 mg gluten per day (equivalent to a few breadcrumbs) can cause significant mucosal damage in CD patients. In CD patients, poor adherence to a GFD is related to anaemia, osteoporosis, infertility, secondary autoimmunity, cancers, and death.
However, because gluten is a major part in most diets, sticking to a GFD can be incredibly difficult. Several investigations have shown that CD patients' adherence to the GFD is poor. Understanding the GFD and food labelling, as well as the cost and availability of GF foods, all have a significant impact on GFD adherence. To ensure long-term dietary adherence, CD patients must be given accurate and thorough information on the GFD and monitored by a healthcare expert on a regular basis. Celiac disease (CD) is only treated with a lifelong gluten-free diet (GFD), which can be difficult. The goal of this study was to learn more about how patients felt about the GFD in terms of challenges, disease-specific symptoms, adherence, and information sources.